Results 101 to 110 of about 126,756 (118)

Chimeric antigen receptor T-cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Sagar Lonial, Rujul Parikh
exaly  

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

Annals of Oncology, 2021
Michael Schmitt, Carsten Müller-Tidow, C A Ramos   +2 more
exaly  

Chimeric Antigen Receptor T-Cell Therapy–Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

Circulation, 2020
Robert Redd, Tariq Azam, Rohan Parikh
exaly  

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies

Cell Transplantation, 2021
Yongxian Hu, Guoqing Wei, Wenjun Wu
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy

OncoImmunology, 2020
Anja Feldmann, Claudia Arndt MHELTHERA, Liliana R Loureiro   +2 more
exaly  

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

Molecular Therapy, 2017
Crystal Mackall, Robbie G Majzner, Terry J Fry   +2 more
exaly  

Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells

MAbs, 2019
Christian Klein, Christian Jost, Sebastian Kobold   +2 more
exaly  

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Molecular Therapy, 2018
Hua Jiang, Zonghai Li, Xiuqi Wu
exaly  

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

Molecular Therapy, 2019
Bruce L. Levine, Gregory L Beatty, Michael C Soulen   +2 more
exaly